Korro Bio (KRRO) News Today → HUGE BUY ALERT: Move Fast, Musk... (From Stansberry Research) (Ad) Free KRRO Stock Alerts $50.05 -0.19 (-0.38%) (As of 05/14/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 14 at 4:01 PM | globenewswire.comKorro Reports First Quarter 2024 Financial Results and Appointment of Kemi Olugemo, M.D. as Chief Medical OfficerApril 29, 2024 | marketbeat.comKorro Bio (NASDAQ:KRRO) Shares Gap Up to $58.53Korro Bio (NASDAQ:KRRO) Shares Gap Up to $58.53April 24, 2024 | marketbeat.comKorro Bio (NASDAQ:KRRO) Shares Down 5.7% Korro Bio (NASDAQ:KRRO) Trading Down 5.7%April 24, 2024 | insidertrades.comInsider Buying: Korro Bio, Inc. (NASDAQ:KRRO) Major Shareholder Buys 17,857 Shares of StockApril 23, 2024 | marketbeat.comKorro Bio, Inc. (NASDAQ:KRRO) Major Shareholder Buys $999,992.00 in StockKorro Bio, Inc. (NASDAQ:KRRO - Get Free Report) major shareholder Venture Opportunity Fund Atlas acquired 17,857 shares of the business's stock in a transaction on Monday, April 22nd. The shares were bought at an average cost of $56.00 per share, with a total value of $999,992.00. Following the completion of the acquisition, the insider now owns 195,074 shares of the company's stock, valued at approximately $10,924,144. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Major shareholders that own more than 10% of a company's stock are required to disclose their transactions with the SEC.April 18, 2024 | marketbeat.comKorro Bio (NASDAQ:KRRO) Shares Down 4% Korro Bio (NASDAQ:KRRO) Shares Down 4%April 18, 2024 | globenewswire.comKorro Announces $70 Million Private PlacementApril 17, 2024 | marketbeat.comKorro Bio (NASDAQ:KRRO) Shares Gap Up to $73.37Korro Bio (NASDAQ:KRRO) Shares Gap Up to $73.37April 9, 2024 | marketbeat.comKorro Bio (NASDAQ:KRRO) Stock Price Down 3.9%Korro Bio (NASDAQ:KRRO) Stock Price Down 3.9%April 8, 2024 | marketbeat.comKorro Bio (NASDAQ:KRRO) Trading Up 5.2%Korro Bio (NASDAQ:KRRO) Shares Up 5.2%April 1, 2024 | globenewswire.comKorro to Participate in Upcoming Investor ConferencesMarch 28, 2024 | marketbeat.comHC Wainwright Increases Korro Bio (NASDAQ:KRRO) Price Target to $115.00HC Wainwright raised their target price on shares of Korro Bio from $100.00 to $115.00 and gave the company a "buy" rating in a report on Thursday.March 27, 2024 | marketbeat.comKorro Bio (NASDAQ:KRRO) Given Overweight Rating at Piper SandlerPiper Sandler reissued an "overweight" rating and set a $180.00 price target on shares of Korro Bio in a research note on Wednesday.March 27, 2024 | marketbeat.comKorro Bio (NASDAQ:KRRO) PT Raised to $90.00Royal Bank of Canada lifted their price target on Korro Bio from $70.00 to $90.00 and gave the company an "outperform" rating in a report on Wednesday.March 26, 2024 | globenewswire.comKorro Reports Full Year 2023 Financial Results and Highlights Recent ProgressFebruary 27, 2024 | globenewswire.comKorro to Present at the TD Cowen 44th Annual Health Care ConferenceFebruary 18, 2024 | seekingalpha.comKorro Bio: An Interesting Platform With A Very Long HorizonNovember 14, 2023 | marketbeat.comTrading was temporarily halted for "KRRO" at 09:11 AM with a stated reason of "LULD pause."November 7, 2023 | marketbeat.comTrading was temporarily halted for "KRRO" at 10:11 AM with a stated reason of "LULD pause."November 7, 2023 | marketbeat.comTrading was temporarily halted for "KRRO" at 10:11 AM with a stated reason of "LULD pause."November 7, 2023 | marketbeat.comTrading was temporarily halted for "KRRO" at 10:11 AM with a stated reason of "LULD pause."November 7, 2023 | marketbeat.comTrading was temporarily halted for "KRRO" at 10:11 AM with a stated reason of "LULD pause."November 7, 2023 | marketbeat.comTrading was temporarily halted for "KRRO" at 10:11 AM with a stated reason of "LULD pause." Get Korro Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for KRRO and its competitors with MarketBeat's FREE daily newsletter. Email Address My system predicted the BA collapse – now it’s issuing an AI warning (Ad)Even after several plane crashes and equipment malfunctions... a congressional hearing... and the worst PR firestorm in recent memory... The FTC's commission chair Lina Khan still deems Boeing (BA), "too big to fail" Click to see why a similar situation is currently brewing in the AI market... KRRO Media Mentions By Week KRRO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KRRO News Sentiment▼1.430.57▲Average Medical News Sentiment KRRO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KRRO Articles This Week▼20▲KRRO Articles Average Week Get Korro Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for KRRO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Heron Therapeutics News Biomea Fusion News Annexon News Lexicon Pharmaceuticals News Neurogene News Mersana Therapeutics News Corbus Pharmaceuticals News Esperion Therapeutics News PepGen News Revance Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KRRO) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersDid Intel Just Dethrone Nvidia?Chaikin AnalyticsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsAmerica’s worst nightmare?Porter & CompanyClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsElon’s New Device is About to Shock the WorldInvestorPlaceInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpaxTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Korro Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
